Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × HMPL-013 × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 3 Stomach Neoplasms 1 Neoplasms 1 NSCLC 1 HER2-positive Colorectal Cancer 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Advanced Malignancies 1 Advanced Colorectal Cancer 1

Interventions

Paclitaxel 20 Dexamethasone 16 Bevacizumab 16 Gemcitabine 15 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Leucovorin 10 Fluorouracil 10 Pemetrexed 9 Epoetin Alfa 9 Cisplatin 9 venetoclax 8 pembrolizumab 8 Prednisone 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 atezolizumab 7 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07270991 2026-02-05

FRUQUITAS

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡